Results 271 to 280 of about 78,813 (321)
Does 0.01% atropine have a place as a myopia control therapy?
Ophthalmic and Physiological Optics, EarlyView.
John R. Phillips+2 more
wiley +1 more source
Background The impact of blood–brain barrier (BBB) leakage on white matter hyperintensity (WMH) subtypes (location) and its association with clinical factors and cognition remains unclear. Purpose To investigate the relationship between WMH volume, permeability, clinical factors, and cognition in older individuals across the cognitive spectrum.
Changmok Lim+6 more
wiley +1 more source
Identification of Ferroptosis-Related Gene in Age-Related Macular Degeneration Using Machine Learning. [PDF]
Zhu M, Yu J.
europepmc +1 more source
Is central vision (and a fovea) needed for emmetropisation?
Ophthalmic and Physiological Optics, EarlyView.
Frank Schaeffel+2 more
wiley +1 more source
Maternal severe obesity and sonographic visualization of fetal anatomy
Abstract Objective We sought to investigate adequacy of fetal anatomic visualization in pregnant patients with BMI ≥ 50 kg/m2 during second trimester fetal anatomic survey. Methods This was a retrospective chart review of singleton pregnancies presenting for fetal anatomic survey from 18 0/7 to 21 6/7 weeks gestation between January 2019 and December ...
Faith Dunn+7 more
wiley +1 more source
A synthesized view of the CSF-blood barrier and its surgical implications for aging disorders. [PDF]
Taha B, McGovern R, Lam C.
europepmc +1 more source
Key lines of discovery in myopia research
Ophthalmic and Physiological Optics, EarlyView.
Frank Schaeffel+3 more
wiley +1 more source
Sequential prenatal diagnosis of fetal skeletal dysplasia: A cohort study
Of the 147 SD fetuses, 58 cases with negative CMA results underwent WES, and 21 genes with pathogenic/likely pathogenic variants were detected in 21 cases, including FGFR3 (n = 11), COL1A1 (n = 2), COL1A2 (n = 1), RUNX2 (n = 1), COL2A1 (n = 1), LMX1B (n = 1), GLI3 (n = 1), DYNC2H1 (n = 1), ALPL (n = 1), and SHOX (n = 1).
Mengting Jiang+5 more
wiley +1 more source
Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy
Abstract Purpose To test the prognostic role of anterior scleral substantia propria (ASSP) thickness in predicting the 3‐month response after half‐dose photodynamic therapy (PDT) in central serous chorioretinopathy (CSCR) and to assess its clinical relevance of ASSP in different CSCR phenotypes.
Paolo Forte+11 more
wiley +1 more source